Overview
Factor V Leiden is a genetic mutation in the Factor V gene that increases the risk of abnormal blood clot formation by making the blood more resistant to the natural anticoagulant protein C. This inherited thrombophilia represents the most common hereditary clotting disorder in populations of European descent. Research published in this journal has examined Factor V Leiden across multiple clinical contexts, including its role in branch retinal vein occlusion, where the mutation contributes to venous thrombotic events affecting retinal circulation. The journal has also addressed Factor V Leiden within comprehensive reviews of inherited bleeding and clotting disorders, exploring the genetic mutations affecting coagulation factors and regulatory proteins that govern hemostasis. Additional investigations have considered thrombophilic factors, including Factor V Leiden, in the context of sudden sensorineural hearing loss, examining whether prothrombotic conditions contribute to vascular compromise in the inner ear. The topic holds clinical significance because Factor V Leiden carriers face elevated risks for venous thromboembolism, and understanding this mutation informs risk stratification, screening decisions in affected families, and management strategies when additional thrombotic risk factors are present, such as pregnancy, surgery, or prolonged immobility.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Understanding Inherited Bleeding Disorders: Genetic Mutations in Blood Coagulation Factors and Regulatory Proteins
A Bit Exagerrated Role of Complete Blood Count Parameters on the Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
MicroRNAs: As A Novel Potential Tool for Diagnosis, Prognosis, and Therapeutic Agents in Hypertension.
How this research is being cited
The 4 articles above have been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · Journal of the American Heart Association
-
2024 · Journal of the American Heart Association
-
S. Sanjay et al. · 2023 · Medical hypothesis, discovery & innovation in optometry
-
2022 · The European Research Journal
-
S. Sanjay et al. · 2022 · Medical hypothesis, discovery & innovation in optometry
-
2022 · Medical Hypothesis Discovery & Innovation in Optometry
-
2022 · The European Research Journal
A sample of recent works citing this journal's research on Factor V Leiden, linking to each citing work.